Jennison Associates
PBYI icon

Jennison Associates’s Puma Biotechnology PBYI Stock Holding History

Jennison Associates’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-488,418
Closed -$22.4M – 695
2018
Q3 		$22.4M Sell
488,418
-462,580
-49% -$22.3M 0.02% 382
2018
Q2 		$56.3M Buy
950,998
+465,453
+96% +$27M 0.05% 248
2018
Q1 		$33M Buy
+485,545
New +$36.4M 0.03% 323
2014
Q3 		– Sell
-214,547
Closed -$14.2M – 743
2014
Q2 		$14.2M Sell
214,547
-215,061
-50% -$15.3M 0.01% 457
2014
Q1 		$44.7M Buy
429,608
+19,943
+5% +$2.34M 0.04% 342
2013
Q4 		$42.4M Sell
409,665
-321,846
-44% -$18.9M 0.04% 340
2013
Q3 		$39.3M Sell
731,511
-183,585
-20% -$9.9M 0.04% 344
2013
Q2 		$40.6M Buy
+915,096
New +$32.3M 0.05% 322

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Jennison Associates's PBYI Position: Q4 2018 in Review

Jennison Associates sold out of Puma Biotechnology (PBYI) in Q4 2018, closing a stake of 488,418 shares — an estimated $22.4M sold.

Jennison Associates first reported a position in PBYI in Q2 2013 and held it in 8 quarters. The position peaked at $56.3M in Q2 2018. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Jennison Associates reported no remaining Puma Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Jennison Associates sold 488,418 Puma Biotechnology shares in Q4 2018, an estimated $22.4M.
  • Jennison Associates first reported a position in Puma Biotechnology in Q2 2013 and held it in 8 quarters.
  • Jennison Associates's Puma Biotechnology position peaked at $56.3M in Q2 2018.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.